| __timestamp | Insmed Incorporated | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 33534999 | 3243000 |
| Thursday, January 1, 2015 | 1982000 | 2472000 |
| Friday, January 1, 2016 | 2438000 | 2548000 |
| Sunday, January 1, 2017 | 2901000 | 19623000 |
| Monday, January 1, 2018 | 2423000 | 30421000 |
| Tuesday, January 1, 2019 | 24212000 | 32793999 |
| Wednesday, January 1, 2020 | 39872000 | 28304000 |
| Friday, January 1, 2021 | 44152000 | 620000 |
| Saturday, January 1, 2022 | 55126000 | 755000 |
| Sunday, January 1, 2023 | 65573000 | 1322000 |
Data in motion
In the dynamic world of biotechnology, understanding cost structures is crucial for investors and stakeholders. Insmed Incorporated and Viridian Therapeutics, Inc. offer a fascinating study in contrasts over the past decade. From 2014 to 2023, Insmed's cost of revenue surged by approximately 95%, reflecting its aggressive expansion and scaling efforts. In contrast, Viridian's cost of revenue exhibited a more volatile trajectory, peaking in 2019 before plummeting by over 95% in 2021. This dramatic shift could indicate strategic pivots or operational efficiencies. Notably, Insmed's consistent upward trend suggests a robust growth strategy, while Viridian's fluctuations may point to adaptive business maneuvers in response to market conditions. As the biotech sector continues to evolve, these trends provide valuable insights into the financial health and strategic directions of these companies.
Cost of Revenue Trends: Novo Nordisk A/S vs Viridian Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Bristol-Myers Squibb Company vs Viridian Therapeutics, Inc.
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Insmed Incorporated
Cost of Revenue: Key Insights for Vertex Pharmaceuticals Incorporated and Viridian Therapeutics, Inc.
Cost of Revenue Trends: Biogen Inc. vs Insmed Incorporated
Cost Insights: Breaking Down Intra-Cellular Therapies, Inc. and Insmed Incorporated's Expenses
Cost of Revenue Comparison: Insmed Incorporated vs Walgreens Boots Alliance, Inc.
Insmed Incorporated vs Exelixis, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Insmed Incorporated and Telix Pharmaceuticals Limited
Cost of Revenue: Key Insights for Insmed Incorporated and Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Bausch Health Companies Inc.
Comparing Cost of Revenue Efficiency: Xenon Pharmaceuticals Inc. vs Viridian Therapeutics, Inc.